Health ❯ Healthcare ❯ Cancer

Breast Cancer

Treatment Screening Programs Treatment Options Awareness Screening Diagnosis Awareness Campaigns Early Detection Mammography Prevention Risk Factors Survivorship Metastatic Breast Cancer Diagnosis and Treatment Mastectomy Surgery Detection Methods Triple-Negative Breast Cancer Patient Care Statistics Screening Guidelines Risk Assessment Screening Issues Detection and Treatment Stage 4 Cancer Breast Density Breast Cancer Awareness Mammograms Stage IV Cancer Screening Protocols Survival Rates Support Systems Detection Programs Screening Methods Breast Cancer Screening Genetic Testing Support Organizations Personal Experiences Symptoms Screening Procedures Stage 4 Breast Cancer Research Radiotherapy HER2-positive Breast Cancer Patient Experience Patient Advocacy Mortality Rates Palliative Care Advanced Breast Cancer Treatment DCIS Treatment Advances Advanced Breast Cancer Awareness and Education Ductal Carcinoma in Situ HR-positive HER2-negative Breast Cancer Ductal Carcinoma In Situ BRCA Mutations Awareness and Prevention Patient Support Cancer Awareness Research Studies Research and Development Screening and Prevention Recovery Screening Recommendations Dormant Cancer Cells Lobular Breast Cancer Charity Work Cancer Treatment Mammography Screening Demographics Screening Processes Chemotherapy Genetics Grief Self-Examination BRCA2 Variants Inflammation Targeted Treatments Gene Expression Stage 3 Breast Cancer Liquid Biopsy Cellular Aging Personalized Medicine Exercise Rehabilitation Treatment Effects Ductal Carcinoma In Situ (DCIS) Chronic Pain ESR1 Mutations Barriers to Detection Screening Statistics Cancer Support Exercise Mental Health Drug Approval Patient Rights Psychological Impact Patient Demographics Surgical Procedures Treatment Access

Lilly’s Imlunestrant Data Show Stronger Results With Abemaciclib, Delayed Chemotherapy in ER+ Breast Cancer

The latest EMBER-3 readout points to meaningful delays before chemotherapy for patients progressing after aromatase inhibitors.

Study Finds No Added Breast Cancer Risk From Menopausal Hormone Therapy in BRCA Carriers

Acupuncture Improves Perceived Cognition With a Modest Memory Edge for Real Needling

Sacituzumab Govitecan Gains First-Line Ground in TNBC, Falls Short in Early HR+/HER2− Use

AI Multimodal Model Outperforms Oncotype DX for Long-Term Breast Cancer Recurrence Risk

Randomized Trial Finds Dense-Breast Notices Raise Anxiety Without Improving Decision-Making

Donyelle Jones, 'So You Think You Can Dance' Season 2 Finalist, Dies at 46

Study at RSNA Finds Up to One in Four Breast Cancers Occur Before Age 50

Hilary Farr Debunks Viral AI Health Hoax, Says She Is 'Alive and Well'

Saverin Foundation Awards $20 Million to Dana-Farber for Metastatic Breast Cancer Research

FDA Approves Poherdy as First Interchangeable Biosimilar to Perjeta for HER2-Positive Breast Cancer

Global Trial Finds Many Post-Mastectomy Patients Can Skip Chest-Wall Radiotherapy

Danielle Fishel Eliminated From DWTS on 7th Anniversary as Husband Posts IV Photo

Hard-to-Detect Breast Cancer Is Rising Faster Than Other Types, New U.S. Study Finds

W Korea Apologizes Over Breast Cancer Gala as Donation Dispute Triggers Probe Calls

Lobular Breast Cancer Is Rising Fast, Now Over 1 in 10 U.S. Cases

UCLA Study Links Inflammation to Specific Fatigue Types After Early-Stage Breast Cancer Treatment

Skipping the First Mammogram Linked to Higher Breast Cancer Death Risk, Study Finds

Garcelle Beauvais Explains RHOBH Exit, Rules Out Near-Term Return

Genetic Risk Score Flags Future Breast Cancer Risk After DCIS or LCIS